{"version":"1.0","provider_name":"IRLAB","provider_url":"https:\/\/irlab.se\/sv\/","title":"Nyemission 2025 - IRLAB","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"DxmALliMuV\"><a href=\"https:\/\/irlab.se\/sv\/investerare\/nyemission-2025\/\">Nyemission 2025<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/irlab.se\/sv\/investerare\/nyemission-2025\/embed\/#?secret=DxmALliMuV\" width=\"600\" height=\"338\" title=\"\u201dNyemission 2025\u201d &ndash; IRLAB\" data-secret=\"DxmALliMuV\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/irlab.se\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"IRLAB v\u00e4xlar upp \u2013 Parkinsonfokus i bred pipeline med global potential Med fem projekt riktade mot olika centrala symtom vid Parkinsons sjukdom positionerar sig det svenska biofarmabolaget IRLAB som en innovativ och differentierad spelare inom neurodegenerativa sjukdomar. Genom en nyemission om cirka 136 miljoner kronor, varav 85 procent \u00e4r garanterad, avser bolaget nu accelerera sina [&hellip;]","thumbnail_url":"https:\/\/irlab.se\/wp-content\/uploads\/2019\/09\/web_retina_DSF9408.jpg","thumbnail_width":2048,"thumbnail_height":1152}